Related Experiment Video
Updated: Sep 26, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
A review of rotavirus diarrhea in Pakistan: how much do we know?
Nadia Kabiruddin Ali1, Zulfiqar A Bhutta
1Department of Paediatrics, The Aga Khan University Hospital, Karachi.
Insights
Rotavirus is a common cause of diarrhea globally, particularly in infants. Further research is needed in Pakistan to understand its disease burden and test vaccine efficacy.
Area of Science:
- Medical Microbiology
- Pediatric Gastroenterology
- Vaccinology
Background:
- Rotavirus diarrhea is a ubiquitous global health concern, affecting nearly all children by age five.
- In Pakistan, rotavirus is a leading cause of diarrheal disease in infants, with the highest incidence in those aged 6-11 months.
- Previous studies indicate rotavirus is a significant enteric pathogen, second only to E. coli in some Pakistani regions.
Purpose of the Study:
- To review the epidemiology, transmission, clinical course, and diagnostic methods of rotavirus in Pakistan.
- To assess the preliminary safety and efficacy of the rotavirus vaccine (RRV) in Pakistani infants.
- To highlight the need for further research on rotavirus disease burden and vaccine trials in Pakistan.
Main Methods:
- Review of existing etiological surveys and clinical studies on rotavirus in Pakistan.
- Analysis of diagnostic modalities, including ELISA, for rotavirus detection in stool samples.
- Evaluation of a study assessing the safety and immunogenicity of the RRV vaccine in infants.
Main Results:
- Rotavirus is a frequent cause of diarrhea in Pakistani infants, with a notable incidence in the 6-11 month age group.
- ELISA demonstrated the highest sensitivity (72.4%) among diagnostic methods for rotavirus detection.
- The RRV vaccine, when co-administered with OPV, showed a 50% increase in neutralization titers and was found to be safe in infants.
Conclusions:
- There is a critical need to define the rotavirus disease burden and prevalent strains in Pakistan.
- Further Rotavirus vaccine trials are essential to evaluate efficacy and safety within the Pakistani context.
Introduction:
Rotavirus diarrhea has a worldwide distribution, infecting almost all children by the age of 3-5 years.
Epidemiology:
A comparable etiological 2-year survey carried out by the W.H.O Diarrheal Disease control (CDD) Program in 1991, in a multicenter study in 5 developing countries including Pakistan revealed that Rotavirus was found to be the most frequently detected pathogen in diarrheal episodes, during the first year of life, with the highest incidence (20%) occurring among 6-11 months old. Two other studies done in Pakistan, in under five children done in Lahore (between 1985 and 1991) and Rawalpindi (between May 1983 and April 1984) showed that Rotavirus was the second most common Diarrhea causing enteric pathogen following E.Coli
Transmission:
Rotaviruses are shed in high concentrations 2 days before and as many as 10 days after onset of symptoms in immunocompetent hosts, thus being an important source of viral transmission.
Clinical Course:
A multicenter study in 5 developing countries including Pakistan conducted by WHO CDD program revealed that only 1.8 % of cases presented with severe dehydration and these were mostly due to Rotavirus, V. Cholerae and ETEC13.
Diagnostic Tests:
A study conducted in local hospitals in Pakistan during the period of October 1985-April 1986 compared the different diagnostic modalities for the detection of rotavirus in the faeces of children with acute diarrhea. The study all methods detected Rotavirus to varying degrees but ELISA was found to be the most sensitive method with 72.4% stools being positive. PREVENTIVE STRATEGIES: A study was conducted in Lahore (Pakistan) among 72 infants 6 weeks old in 1991 to assess safety and efficacy of RRV vaccine. It was found that of all infants given RRV with OPV, 50% had a two to four-fold rise in neutralization titers against rotavirus. RRV was found to be safe and not associated with adverse reactions in the 6 weeks old infants.
Conclusion:
With regards to Pakistan, there is a great need for defining rotavirus associated disease burden and strain prevalence. We also need to conduct Rotavirus vaccine trials to assess its efficacy and safety in our setting.
Related Concept Videos
Poliomyelitis
Cholera
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Bacterial Gastroenteritis
Respiratory Syncytial Virus Disease
Investigation of Disease Outbreaks
